Home›Stock Screener›Glenmark Pharmaceuticals›P/E Ratio

Glenmark Pharmaceuticals P/E Ratio

Current P/E Ratio
59.86
High Valuation
Very High - High growth expectations or significantly overvalued

Glenmark Pharmaceuticals (GLENMARK) P/E ratio is 59.86 (High), EPS (TTM) ₹37.11, current price ₹2384.90 on NSE vs historical average P/E of 22.92 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Browse GLENMARK cash flow statement for revenue, profit, balance sheet and cash flow data.

Current Valuation Metrics

P/E Ratio 59.86
Current Price ₹2384.90
EPS (TTM) ₹37.11
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.92
Historical Range 10.2 - 42.78
Percentile 100.0%

Sector Context

Sector Average 48.99
Sector Median 28.77
Sector Rank #11 of 193
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹37.74
Sept 2025 ₹21.63
Mar 2025 ₹0.16

GLENMARK P/E Ratio — Valuation Signal & Historical Context

Glenmark Pharmaceuticals P/E 59.86 vs historical average 22.92, range 10.2–42.78 — signal: Overvalued. Analyse GLENMARK institutional holdings to track promoter, FII and institutional holdings.

  • Stock appears overvalued with PE of 59.86, suggesting caution for new investments
  • Current PE is 161.1% above historical average
  • Trading at premium to sector average PE of 48.99

Glenmark Pharmaceuticals P/E Ratio Historical Trend

GLENMARK annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 59.86 vs historical average 22.92. For live price, revenue and the complete fundamental profile, see Glenmark Pharmaceuticals share price today.

GLENMARK Historical P/E Ratio — EPS, Year-End Price & Valuation

Glenmark Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.78 37.74 ₹1614.50 NSE High
2022 16.82 31.22 ₹525.25 NSE Moderate
2021 13.91 36.14 ₹502.60 NSE Low
2020 10.2 33.9 ₹345.70 NSE Low
2019 27.23 25.42 ₹692.15 NSE High
2018 18.39 32.42 ₹596.10 NSE Moderate
2017 29.84 29.62 ₹884.00 NSE High
2016 24.21 38.15 ₹923.75 NSE Moderate

GLENMARK vs Healthcare Peers — P/E Ratio Comparison

Glenmark Pharmaceuticals P/E 59.86 vs Healthcare average 48.99, median 28.77 — range 0.97–869.57.

Sector Average
48.99
Sector Median
28.77
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.97 ₹36 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.13 ₹53 Low
Sun Pharma Advanced Rese… SPARC 4.39 ₹7,561 Low
Ind Swift Laboratories INDSWFTLAB 4.61 ₹1,146 Low
Amwill Health Care AMWILL 6.04 ₹65 Low
Mono Pharmacare MONOPHARMA 6.85 ₹20 Low
Medicamen Organics MEDIORG 6.94 ₹28 Low
Brooks Laboratories BROOKS 7.38 ₹166 Low
Shelter Pharma SHELTER 7.4 ₹54 Low